677 related articles for article (PubMed ID: 25901937)
1. Mouse bone marrow-derived mesenchymal stem cells inhibit leukemia/lymphoma cell proliferation in vitro and in a mouse model of allogeneic bone marrow transplant.
Song N; Gao L; Qiu H; Huang C; Cheng H; Zhou H; Lv S; Chen L; Wang J
Int J Mol Med; 2015 Jul; 36(1):139-49. PubMed ID: 25901937
[TBL] [Abstract][Full Text] [Related]
2. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
[TBL] [Abstract][Full Text] [Related]
3. [Effect of bone marrow mesenchymal stem cells on acute graft versus host disease and graft versus leukemia after allogeneic bone marrow transplantation].
Hu WB; Gao QP; Chen YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):404-7. PubMed ID: 15972130
[TBL] [Abstract][Full Text] [Related]
4. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
[TBL] [Abstract][Full Text] [Related]
5. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
[TBL] [Abstract][Full Text] [Related]
6. [The role of marrow derived mesenchymal stem cells in the prevention and treatment of acute graft-versus-host in mice.].
Bao XC; Wang JM; Zhang WP; Zhou H; Zheng XL; Gao L
Zhonghua Xue Ye Xue Za Zhi; 2010 Feb; 31(2):108-13. PubMed ID: 20302798
[TBL] [Abstract][Full Text] [Related]
7. Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease.
Kim KW; Moon SJ; Park MJ; Kim BM; Kim EK; Lee SH; Lee EJ; Chung BH; Yang CW; Cho ML
Stem Cell Res Ther; 2015 Oct; 6():202. PubMed ID: 26497134
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.
Schmidt F; Hilger N; Oelkrug C; Svanidze E; Ruschpler P; Eichler W; Boldt A; Emmrich F; Fricke S
Cytometry A; 2015 Apr; 87(4):334-45. PubMed ID: 25717029
[TBL] [Abstract][Full Text] [Related]
9. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
[TBL] [Abstract][Full Text] [Related]
10. [The role of third-party tolerogenic dendritic cells in the prevention of acute graft-versus-host-disease following allogeneic bone marrow transplantation in mice].
Li GP; Yang J; Hao J; Yang YM; Ren YN; Xie RF; Fan HH; Qian KC
Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):461-6. PubMed ID: 22967381
[TBL] [Abstract][Full Text] [Related]
11. [Effect of human bone marrow mesenchymal stem cell on allogeneic T lymphocyte phenotype in vitro].
Ning HM; Jin JG; Hu JW; Feng K; Chen H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):43-9. PubMed ID: 15748434
[TBL] [Abstract][Full Text] [Related]
12. [Experiment study of efficacy on hematopoietic reconstitution and GVHD prophylaxis after mesenchymal cell infused by intra-bone marrow cavity or intravenous in rat BMT models].
Huang K; Huang SL; Zhou DH; Cai Y; Zhang XC; Li Y
Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):87-92. PubMed ID: 17650667
[TBL] [Abstract][Full Text] [Related]
13. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory function of whole human umbilical cord derived mesenchymal stem cells.
Zhang H; Tao Y; Liu H; Ren S; Zhang B; Chen H
Mol Immunol; 2017 Jul; 87():293-299. PubMed ID: 28531813
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
Tian Y; Deng YB; Huang YJ; Wang Y
Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
[TBL] [Abstract][Full Text] [Related]
16. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease.
Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216
[TBL] [Abstract][Full Text] [Related]
17. Human tonsil‑derived mesenchymal stromal cells enhanced myelopoiesis in a mouse model of allogeneic bone marrow transplantation.
Ryu JH; Park M; Kim BK; Kim YH; Woo SY; Ryu KH
Mol Med Rep; 2016 Oct; 14(4):3045-51. PubMed ID: 27511380
[TBL] [Abstract][Full Text] [Related]
18. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
[TBL] [Abstract][Full Text] [Related]
19. The triterpenoid CDDO-Me delays murine acute graft-versus-host disease with the preservation of graft-versus-tumor effects after allogeneic bone marrow transplantation.
Li M; Sun K; Redelman D; Welniak LA; Murphy WJ
Biol Blood Marrow Transplant; 2010 Jun; 16(6):739-50. PubMed ID: 20338256
[TBL] [Abstract][Full Text] [Related]
20. [Study of immuno-tolerance mechanism of the third-party bone marrow-derived mesenchymal stem cells in allogenic transplantation].
Qi BD; Meng BX; Yang Y; Liu B; Li CC; Xia W; Guo SZ; Zhang C
Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 May; 27(3):207-12. PubMed ID: 21838003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
